Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: A study of 12 cases

Journal of Clinical Rheumatology

Volumn 15, Issue 7, 2009, Pages 341-344

  Lin, Yi ^a   Zheng, Wenjie ^b   Tian, Xinping ^b   Zhang, Xuan ^b   Zhang, Fengchun ^b   Dong, Yi ^b  

^a Department of Internal Medicine ^*

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

ANCA associated vasculitis; Diffuse alveolar hemorrhage

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTHRALGIA; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE DURATION; DYSPNEA; EAR NOSE THROAT DISEASE; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; HEART FAILURE; HEMOPTYSIS; HUMAN; LABORATORY TEST; LUNG HEMORRHAGE; MALE; MEDICAL RECORD REVIEW; MORTALITY; MYALGIA; MYCOSIS; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; RATING SCALE; RESPIRATORY FAILURE; SEPTIC SHOCK; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BRONCHIAL DISEASES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HEMORRHAGE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PLASMAPHERESIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70350146516     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181b59581     Document Type: Article

References (18)

1. Lauque D, Cadranel J, Lazor R, et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine (Baltimore). 2000;79:222-233.
2. Betensley AD, Yankaskas JR. Factor viia for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med. 2002;166:1291-1292.
3. Matsushima H, Takayanagi N, Ubukata M, et al. Churg-Strauss syndrome with alveolar hemorrhage(Japanese). Nihon Kokyuki Gakkai Zasshi. 2003;41: 25-29.
4. Vuotto F, Queyrel V, Lambert M, et al. MPO-ANCA related vasculitis presenting as chronic iron deficiency anemia due to paucisymptomatic intraalveolar haemorrhage (French). Rev Med Interne. 2007;28:484-487.
5. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
6. De Lassence A, Fleury-Feith J, Escudier E, et al. Alveolar hemorrhage. Diagnostic Criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med. 1995;151:157-163.
7. Luqmani R, Bacon PA, Janssen B, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87:671-678.
8. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
9. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421-430.
10. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome: clinical study and long term follow-up of 96 patients. Medicine (Baltimore). 1999; 78:26-37.
11. Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990;87:4115-4119.
12. Hogan SL, Nachman PH, Wilkman AS, et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23-32.
13. Franssen C, Gans R, Kallenberg C, et al. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and antimyeloperoxidase autoantibodies. J Intern Med. 1998;244:209-216.
14. Franssen CF, Gans RO, Arends B, et al. Difference between antimyeloperoxidase and anti-proteinase-3 associated renal disease. Kidney Int. 1995;47: 193-199.
15. Nachman PH, Hogan SL, Jennette JC, et al. Treatment response and relapse in antineutrophil cytoplasmic antoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:33-39.
16. Klemmer PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis. 2003;42:1149-1153.
17. Cruz BA, Ramanoelina J, Mahr A, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford). 2003;42:1183-1188.
18. Holguin F, Ramadan B, Gal AA, et al. Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci. 2008;336:321-326.